Submitted by Anonymous (not verified) on 26 January 2026 - 15:10
Human medicines European public assessment report (EPAR): Triumeq, abacavir,dolutegravir,lamivudine, Date of authorisation: 31/08/2014, Revision: 39, Status: Authorised
Source: